Skip to main content
. 2022 Sep 6;156:105292. doi: 10.1016/j.jcv.2022.105292

Table 4.

Sensitivity and specificity of RBD, TrimericS, Elecsys and cPass calculated by using user-defined clinically positive reference standard.

N = 180 Compared to clinically positive Samples (3/4 assays positive)
Sensitivity Specificity TP TN FP FN
Abbott Architect RBD 100.0% 95.7% 88 88 4 0
DiaSorin Trimeric S 100.0% 97.8% 88 90 2 0
Roche Elecsys 100.0% 88.0% 88 81 11 0
GenScript cPass 89.8% 100.0% 79 92 0 9